Berry Invests in its China Facility
Evansville-based Berry Global Group Inc. (NYSE: BERY) says it is investing in state-of-the-art technology to increase production capacity to serve fast-growing Asia healthcare markets.
The plastics-focused manufacturer says the equipment, Reicofil R5, is critical in the manufacturing of healthcare nonwoven materials, primarily surgical drapes and gowns.
The company says this is the second state-of-the-art R5 unit to be installed at the site.
Berry says the equipment will be installed at Berry’s Nanhai, China, facility, which serves customers in the rapidly growing Southeast Asia region.
“We are committed to further partnering with our customers to pursue growth opportunities around the world. The added capacity achieved through this asset is a next step in advancing our market-leading position in healthcare material solutions,” said Curt Begle, president of Berry’s Health, Hygiene, and Specialties Division.
The company expects the technology will be operating in the fourth quarter of 2022.